Oppenheimer Asset Management Inc. bought a new stake in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) during the first quarter, Holdings Channel reports. The fund bought 145,470 shares of the pharmacy operator’s stock, valued at approximately $12,081,000.

Several other large investors have also recently modified their holdings of WBA. Chesley Taft & Associates LLC boosted its stake in shares of Walgreens Boots Alliance by 1.4% in the first quarter. Chesley Taft & Associates LLC now owns 174,098 shares of the pharmacy operator’s stock valued at $14,459,000 after buying an additional 2,462 shares during the last quarter. Gulf International Bank UK Ltd boosted its stake in shares of Walgreens Boots Alliance by 1.8% in the first quarter. Gulf International Bank UK Ltd now owns 286,363 shares of the pharmacy operator’s stock valued at $23,782,000 after buying an additional 4,970 shares during the last quarter. Lynch & Associates IN boosted its stake in shares of Walgreens Boots Alliance by 0.3% in the first quarter. Lynch & Associates IN now owns 46,177 shares of the pharmacy operator’s stock valued at $3,835,000 after buying an additional 125 shares during the last quarter. Koshinski Asset Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 25.3% in the first quarter. Koshinski Asset Management Inc. now owns 9,109 shares of the pharmacy operator’s stock valued at $756,000 after buying an additional 1,841 shares during the last quarter. Finally, Quadrant Capital Group LLC boosted its stake in shares of Walgreens Boots Alliance by 2.8% in the first quarter. Quadrant Capital Group LLC now owns 7,246 shares of the pharmacy operator’s stock valued at $587,000 after buying an additional 200 shares during the last quarter. 61.17% of the stock is currently owned by hedge funds and other institutional investors.

Shares of Walgreens Boots Alliance, Inc. (WBA) traded up 0.834% during mid-day trading on Friday, hitting $80.415. The company had a trading volume of 1,128,825 shares. The firm has a 50-day moving average price of $78.96 and a 200 day moving average price of $82.30. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69. The firm has a market capitalization of $86.05 billion, a price-to-earnings ratio of 20.307 and a beta of 1.25.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The firm had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same period last year, the business earned $1.18 EPS. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% compared to the same quarter last year. Analysts expect that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be paid a dividend of $0.40 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 2.01%. The ex-dividend date is Wednesday, August 16th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 37.78%.

Walgreens Boots Alliance declared that its board has approved a share repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to repurchase up to 5.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

TRADEMARK VIOLATION WARNING: This piece was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was stolen and reposted in violation of US and international copyright and trademark law. The original version of this piece can be accessed at https://www.watchlistnews.com/oppenheimer-asset-management-inc-takes-position-in-walgreens-boots-alliance-inc-nasdaqwba/1475373.html.

Several equities research analysts have weighed in on WBA shares. Morgan Stanley reissued an “overweight” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Citigroup Inc. reissued a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Thursday, August 3rd. Guggenheim reissued a “buy” rating on shares of Walgreens Boots Alliance in a research note on Monday, July 3rd. Finally, Jefferies Group LLC reduced their price objective on Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 31st. Two research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have given a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $90.69.

In related news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now directly owns 19,151 shares in the company, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 13.50% of the stock is owned by company insiders.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.